GlassScriptPhysician profile
Sterling I Barrett
NPI 1104812551
$2,074.52
in general payments reported to CMS, 2019-2025
21 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $190 · 2021: $224 · 2022: $215 · 2023: $218 · 2024: $626 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $439.63 | 2019-2025 | |
| Glaxosmithkline, LLC. | $359.80 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $316.20 | 2019-2024 | |
| Abbvie INC. | $144.50 | 2021-2024 | Avycaz, Teflaro |
| Novo Nordisk INC | $124.56 | 2022-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.66 | 2022-2024 | Jardiance, Spiriva Respimat |
| Sanofi-Aventis U.S. LLC | $83.16 | 2024-2025 | |
| Amgen INC. | $80.06 | 2019-2023 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $58.49 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.29 | 2019-2021 | |
| Inspire Medical Systems, INC. | $55.66 | 2024 | Inspire |
| Lilly USA, LLC | $49.33 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $39.40 | 2022 | |
| Eisai INC. | $32.96 | 2021-2022 | |
| Abiomed | $32.48 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $28.87 | 2019 | |
| Neuronetics, INC. | $17.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.43 | 2024 | Airsupra |
| Ibsa Pharma INC. | $14.23 | 2025 | Flector, Licart, Tirosint |
| Vistapharm, INC. | $13.62 | 2021 | |
| Senseonics, Incorporated | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sterling Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.